NIRAVAM TM 2 mg orally disintegrating tablets, single dose
Sponsors
Actavis Inc.
Conditions
Healthy
Phase 1
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions
CompletedNCT01188057
Start: 2006-07-31End: 2006-08-31Updated: 2010-08-25
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions
CompletedNCT01188031
Start: 2006-06-30End: 2006-07-31Updated: 2010-08-25